Ensign Peak Advisors’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-148,773
| Closed | -$2.49M | – | 1712 |
|
|
2024
Q3 | $2.49M | Hold |
148,773
| – | – | ﹤0.01% | 854 |
|
|
2024
Q2 | $2.59M | Buy |
+148,773
| New | +$2.59M | ﹤0.01% | 810 |
|
|
2022
Q4 | – | Sell |
-2,400
| Closed | -$31K | – | 1868 |
|
|
2022
Q3 | $31K | Buy |
2,400
+330
| +16% | +$4.26K | ﹤0.01% | 2274 |
|
|
2022
Q2 | $27K | Hold |
2,070
| – | – | ﹤0.01% | 2112 |
|
|
2022
Q1 | $22K | Hold |
2,070
| – | – | ﹤0.01% | 2174 |
|
|
2021
Q4 | $32K | Sell |
2,070
-10,142
| -83% | -$157K | ﹤0.01% | 2163 |
|
|
2021
Q3 | $276K | Buy |
12,212
+7,212
| +144% | +$163K | ﹤0.01% | 1715 |
|
|
2021
Q2 | $129K | Hold |
5,000
| – | – | ﹤0.01% | 1763 |
|
|
2021
Q1 | $208K | Buy |
+5,000
| New | +$208K | ﹤0.01% | 1723 |
|